vs
CRYO CELL INTERNATIONAL INC（CCEL）与NexPoint Real Estate Finance, Inc.（NREF）财务数据对比。点击上方公司名可切换其他公司
NexPoint Real Estate Finance, Inc.的季度营收约是CRYO CELL INTERNATIONAL INC的1.4倍（$11.1M vs $7.8M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -48.7%，领先265.3%），CRYO CELL INTERNATIONAL INC同比增速更快（-2.3% vs -48.8%）
Cryo-Cell国际是一家脐带血库企业，由丹·理查德于1989年创立，是全球首家分离并储存干细胞的民营脐带血库，总部位于佛罗里达州奥兹马尔，地处坦帕市郊。
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
CCEL vs NREF — 直观对比
营收规模更大
NREF
是对方的1.4倍
$7.8M
营收增速更快
CCEL
高出46.6%
-48.8%
净利率更高
NREF
高出265.3%
-48.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.8M | $11.1M |
| 净利润 | $-3.8M | $24.0M |
| 毛利率 | 77.9% | — |
| 营业利润率 | -50.6% | — |
| 净利率 | -48.7% | 216.6% |
| 营收同比 | -2.3% | -48.8% |
| 净利润同比 | -105.1% | 58.7% |
| 每股收益（稀释后） | $-0.46 | $0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCELNREF
| Q4 25 | $7.8M | $11.1M | ||
| Q3 25 | $7.8M | $12.5M | ||
| Q2 25 | $7.9M | $12.1M | ||
| Q1 25 | $8.0M | $11.5M | ||
| Q4 24 | $8.0M | $21.7M | ||
| Q3 24 | $8.1M | $12.5M | ||
| Q2 24 | $8.0M | $6.7M | ||
| Q1 24 | $7.9M | $-12.8M |
净利润CCELNREF
| Q4 25 | $-3.8M | $24.0M | ||
| Q3 25 | $749.4K | $50.9M | ||
| Q2 25 | $355.8K | $22.3M | ||
| Q1 25 | $282.9K | $26.0M | ||
| Q4 24 | $-1.9M | $15.2M | ||
| Q3 24 | $1.1M | $23.3M | ||
| Q2 24 | $655.8K | $12.1M | ||
| Q1 24 | $556.2K | $-14.6M |
毛利率CCELNREF
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
营业利润率CCELNREF
| Q4 25 | -50.6% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 18.8% | — | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | 17.2% | — | ||
| Q2 24 | 17.3% | — | ||
| Q1 24 | 10.5% | — |
净利率CCELNREF
| Q4 25 | -48.7% | 216.6% | ||
| Q3 25 | 9.6% | 407.0% | ||
| Q2 25 | 4.5% | 184.5% | ||
| Q1 25 | 3.5% | 225.6% | ||
| Q4 24 | -23.2% | 69.9% | ||
| Q3 24 | 13.0% | 186.4% | ||
| Q2 24 | 8.2% | 179.7% | ||
| Q1 24 | 7.1% | 114.3% |
每股收益（稀释后）CCELNREF
| Q4 25 | $-0.46 | $0.47 | ||
| Q3 25 | $0.09 | $1.14 | ||
| Q2 25 | $0.04 | $0.54 | ||
| Q1 25 | $0.03 | $0.70 | ||
| Q4 24 | $-0.23 | $0.71 | ||
| Q3 24 | $0.13 | $0.74 | ||
| Q2 24 | $0.08 | $0.40 | ||
| Q1 24 | $0.07 | $-0.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.3M | $31.1M |
| 总债务越低越好 | $8.4M | $771.2M |
| 股东权益账面价值 | $-18.6M | $388.0M |
| 总资产 | $61.7M | $5.3B |
| 负债/权益比越低杠杆越低 | — | 1.99× |
8季度趋势，按日历期对齐
现金及短期投资CCELNREF
| Q4 25 | $3.3M | $31.1M | ||
| Q3 25 | $3.2M | $17.9M | ||
| Q2 25 | $4.4M | $9.1M | ||
| Q1 25 | $3.5M | $19.2M | ||
| Q4 24 | $3.5M | $3.9M | ||
| Q3 24 | $2.1M | $34.7M | ||
| Q2 24 | $1.5M | $4.3M | ||
| Q1 24 | $979.6K | $13.5M |
总债务CCELNREF
| Q4 25 | $8.4M | $771.2M | ||
| Q3 25 | $8.4M | $720.9M | ||
| Q2 25 | $8.4M | $815.6M | ||
| Q1 25 | $8.5M | $831.5M | ||
| Q4 24 | $8.5M | $799.3M | ||
| Q3 24 | $8.5M | $815.5M | ||
| Q2 24 | $8.5M | $861.0M | ||
| Q1 24 | $8.6M | $843.3M |
股东权益CCELNREF
| Q4 25 | $-18.6M | $388.0M | ||
| Q3 25 | $-14.8M | $375.4M | ||
| Q2 25 | $-15.6M | $348.2M | ||
| Q1 25 | $-14.7M | $343.7M | ||
| Q4 24 | $-13.2M | $336.5M | ||
| Q3 24 | $-9.6M | $335.8M | ||
| Q2 24 | $-10.7M | $327.5M | ||
| Q1 24 | $-10.3M | $327.1M |
总资产CCELNREF
| Q4 25 | $61.7M | $5.3B | ||
| Q3 25 | $63.2M | $5.3B | ||
| Q2 25 | $64.4M | $5.4B | ||
| Q1 25 | $64.4M | $5.4B | ||
| Q4 24 | $64.7M | $5.4B | ||
| Q3 24 | $62.9M | $5.7B | ||
| Q2 24 | $62.6M | $6.6B | ||
| Q1 24 | $61.7M | $7.1B |
负债/权益比CCELNREF
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-4.5M |
| 自由现金流经营现金流 - 资本支出 | $1.2M | — |
| 自由现金流率自由现金流/营收 | 15.5% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | — | -0.19× |
| 过去12个月自由现金流最近4个季度 | $5.2M | — |
8季度趋势，按日历期对齐
经营现金流CCELNREF
| Q4 25 | $1.3M | $-4.5M | ||
| Q3 25 | $2.5M | $8.1M | ||
| Q2 25 | $707.0K | $3.3M | ||
| Q1 25 | $954.1K | $16.0M | ||
| Q4 24 | $2.2M | $4.4M | ||
| Q3 24 | $2.4M | $14.7M | ||
| Q2 24 | $1.8M | $-7.5M | ||
| Q1 24 | $-356.9K | $17.7M |
自由现金流CCELNREF
| Q4 25 | $1.2M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | — | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
自由现金流率CCELNREF
| Q4 25 | 15.5% | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
资本支出强度CCELNREF
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
现金转化率CCELNREF
| Q4 25 | — | -0.19× | ||
| Q3 25 | 3.38× | 0.16× | ||
| Q2 25 | 1.99× | 0.15× | ||
| Q1 25 | 3.37× | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | 2.32× | 0.63× | ||
| Q2 24 | 2.70× | -0.62× | ||
| Q1 24 | -0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
